1. Home
  2. GDS vs RGEN Comparison

GDS vs RGEN Comparison

Compare GDS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GDS Holdings Limited ADS

GDS

GDS Holdings Limited ADS

HOLD

Current Price

$29.83

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$142.40

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDS
RGEN
Founded
2001
1981
Country
China
United States
Employees
2434
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
GDS
RGEN
Price
$29.83
$142.40
Analyst Decision
Strong Buy
Buy
Analyst Count
7
12
Target Price
$45.27
$167.67
AVG Volume (30 Days)
2.5M
1.1M
Earning Date
05-19-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$12.93
$14.30
Revenue Next Year
$13.27
$14.52
P/E Ratio
$52.69
$927.07
Revenue Growth
N/A
35.10
52 Week Low
$26.97
$100.99
52 Week High
$48.61
$175.77

Technical Indicators

Market Signals
Indicator
GDS
RGEN
Relative Strength Index (RSI) 36.48 61.53
Support Level $26.97 $123.05
Resistance Level $37.45 $141.46
Average True Range (ATR) 1.62 6.31
MACD 0.08 0.44
Stochastic Oscillator 22.30 68.45

Price Performance

Historical Comparison
GDS
RGEN

About GDS GDS Holdings Limited ADS

GDS Holdings started as an IT service provider in 2001, then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates, and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China, and it has also started expanding into Southeast Asia via the now 23% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: